Unfortunately, you have to subscribe to read the rest of this post, but I wanted to go ahead and post the teaser blurb>
From FDANews.com:
Devicemakers may face an increase in indictments as the Justice Department zeroes in on Foreign Corrupt Practices Act (FCPA) violations. Justice’s FCPA and healthcare fraud units are beginning to work together to investigate FCPA violations in the device and pharmaceutical industries, Lanny Breuer, Justice assistant attorney general, said at the Pharmaceutical Regulatory and Compliance Congress. He noted that Justice is working more closely with the SEC, and international cooperation and information sharing is increasing as well…
